Virpax Pharmaceuticals

(OTC) VRPX

Current Price$0.01

Market Cap$13,800

Since IPO (2021)-100%

5 Year-100%

1 Year-95%

1 Month+38%

Virpax Pharmaceuticals Financials at a Glance

Market Cap

$13,800

Revenue (TTM)

$0.00

Net Income (TTM)

$12.07M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-1101.97 (Low)

Dividend

$0.00

Beta (Volatility)

-1101.97 (Low)

Price

$0.01

Volume

Open

$0.01

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.48

Dividend

$0.00

Beta (Volatility)

-1101.97 (Low)

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.48

VRPX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Virpax Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Jay Dhaliwal

Website

www.virpaxpharma.com

Headquarters

Berwyn, PA 19312, US

VRPX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

13%

Return on Assets

-8%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.80K

Shares Outstanding

1.24M

Volume

Avg. Volume

453.825

Financials (TTM)

Gross Profit

$0.00

Operating Income

$12.08M

EBITDA

$11.96M

Operating Cash Flow

$16.71B

Capital Expenditure

$0.00

Free Cash Flow

$16.71B

Cash & ST Invst.

$1.51M

Total Debt

$0.00

Virpax Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$13.80K

N/A

Market Cap/Employee

$6.90K

N/A

Employees

N/A

Net Income

$3.39M

+25.7%

EBITDA

$3.39M

+25.7%

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Net Cash

$1.51M

-83.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-7.76%

N/A

Return on Invested Capital

13.22%

N/A

Free Cash Flow

$2.87M

+4.7%

Operating Cash Flow

$2.87M

+4.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SLXNWSilexion Therapeutics Ltd.

SLXNWSilexion Therapeutics Ltd.$0.01-14.34%

SYRSSyros Pharmaceuticals, Inc.

SYRSSyros Pharmaceuticals, Inc.$0.00+0.00%

FOXOFOXO Technologies Inc.

FOXOFOXO Technologies Inc.$0.00+0.00%

VINCVincerx Pharma, Inc.

VINCVincerx Pharma, Inc.$0.01+1.18%

PPBTPurple Biotech Ltd.

PPBTPurple Biotech Ltd.$4.06-1.58%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.22-3.17%

ACONAclarion, Inc.

ACONAclarion, Inc.$3.10-2.67%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.40-0.00%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$6.82-0.09%

MARAMara Holdings

MARAMara Holdings$13.53+0.05%

NOKNokia

NOKNokia$13.89+0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.83+0.08%

NVDANvidia

NVDANvidia$219.28+0.02%

INTCIntel

INTCIntel$129.37+0.04%

Questions About VRPX

What is the current price of Virpax Pharmaceuticals?

Virpax Pharmaceuticals is trading at $0.01 per share.

What is the 52-week range for Virpax Pharmaceuticals?

Over the past 52 weeks, Virpax Pharmaceuticals has traded between $0.01 and $0.48.

How much debt does Virpax Pharmaceuticals have?

As of the most recent reporting period, Virpax Pharmaceuticals reported total debt of N/A.

How much cash does Virpax Pharmaceuticals have on hand?

Virpax Pharmaceuticals reported $1.51M in cash and cash equivalents in its most recent financial results.

What is Virpax Pharmaceuticals’s dividend yield?

Virpax Pharmaceuticals does not currently have a dividend yield.

Virpax Pharmaceuticals

Virpax Pharmaceuticals Financials at a Glance

VRPX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Virpax Pharmaceuticals

VRPX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Virpax Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VRPX

What is the current price of Virpax Pharmaceuticals?

What is the 52-week range for Virpax Pharmaceuticals?

How much debt does Virpax Pharmaceuticals have?

How much cash does Virpax Pharmaceuticals have on hand?

What is Virpax Pharmaceuticals’s dividend yield?

Premium Investing Services